Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Viona
FDA Approves METFORMIN HYDROCHLORIDE — Viona Pharmaceuticals Inc

Viona Pharmaceuticals Inc. has confirmed the approval of its Abbreviated New Drug Application for METFORMIN HYDROCHLORIDE (ANDA077060), a critical ora...

WATSON
FDA Approves Unknown Drug — WATSON LABS

# FDA Approves Watson Labs Generic Drug Application Watson Labs received FDA approval for abbreviated new drug application ANDA076417 on April 18, 20...

ZYDUS
FDA Approves Unknown Drug — ZYDUS PHARMS USA

Zydus Pharmaceuticals USA has received FDA approval for ANDA077064, permitting the launch of a new generic drug. This regulatory clearance positions t...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS LABS FL INC

On April 12, 2005, the U.S. FDA approved Actavis Labs FL Inc.'s ANDA for a new generic drug, signaling an impending entry of a branded competitor to t...

Sun
FDA Approves CICLOPIROX OLAMINE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. announced the approval to manufacture and market Ciclopirox Olamine following the FDA's greenlight of ANDA 076790....

TEVA
FDA Approves Unknown Drug — TEVA

On April 12, 2005, Teva Pharmaceutical Industries received approval for Abbreviated New Drug Application #ANDA076864, signaling the company’s continue...

E.R.
FDA Approves BARACLUDE — E.R. Squibb & Sons, L.L.C.

E.R. Squibb & Sons, L.L.C. received FDA approval for Baraclude (entecavir) oral tablets in March 2005, positioning it as a potent therapeutic option f...

E.R.
FDA Approves BARACLUDE — E.R. Squibb & Sons, L.L.C.

E.R. Squibb & Sons, L.L.C. received FDA approval on March 29, 2005, for BARACLUDE (entecavir), an oral antiviral indicated for the treatment of chroni...

Mylan
FDA Approves FENTANYL — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. received FDA approval for its Abbreviated New Drug Application for transdermal fentanyl, authorizing the launch of a generi...

Aurobindo
FDA Approves METFORMIN HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma has received FDA approval for its abbreviated new drug application (ANDA) for Metformin Hydrochloride, signaling a new entry for this...

URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.

Uronova Pharmaceuticals’ approval of its subcutaneous leuprolide acetate injection introduces new competition in the hormone therapy market, providing...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

Sandoz received FDA approval on December 14, 2004, for its Abbreviated New Drug Application (ANDA076223), signaling a significant move downstream in t...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

Sandoz has secured FDA approval for Abbreviated New Drug Application (ANDA) ANDA076873 on December 14, 2004, which will allow the company to immediate...

APOTEX
FDA Approves Unknown Drug — APOTEX

APOTEX has received approval from the US Food and Drug Administration for ANDA076706, a move that grants the company entry into the established market...

WATSON
FDA Approves Unknown Drug — WATSON LABS INC

Watson Labs Inc. received FDA approval for ANDA076818 on December 14, 2004, marking another successful entry into the market as a pharmaceutical gener...

Hikma
FDA Approves LITHIUM CARBONATE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. has announced the initiation of 180-day generic exclusivity for lithium carbonate oral tablets, replacing the Teva bran...

Chattem,
FDA Approves ALLEGRA-D ALLERGY AND CONGESTION — Chattem, Inc.

Chattem, Inc. has secured approval for the new combination form of ALLEGRA-D ALLERGY AND CONGESTION, featuring fexofenadine hydrochloride and pseudoep...

BARR
FDA Approves Unknown Drug — BARR

Barr Laboratories announced on October 14, 2004, that its Abbreviated New Drug Application for demeclocycline hydrochloride tablets was approved by th...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS

Teva Pharmaceutical has announced the U.S. Food and Drug Administration's approval of an Abbreviated New Drug Application, potentially unlocking signi...

Hikma
FDA Approves ALLOPURINOL SODIUM — Hikma Pharmaceuticals USA Inc.

# FDA Approves Hikma Pharmaceuticals' Intravenous Allopurinol Sodium Formulation Hikma Pharmaceuticals USA Inc. received FDA approval for allopurinol...